RXRXRecursion Pharmaceuticals, Inc.

3.500USD0.00%Mkt Cap: 1.88B $P/E:

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and eng…

Key Statistics

Company
Market Cap1.88B $
Enterprise Value1.31B $
Revenue (TTM)54.86M $
Gross Profit3.30M $
Net Income (TTM)-644.76M $
Revenue/Share0.1080 USD
Last Price3.500 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees600
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-3.73
PEG
EV/EBITDA-2.78
EV/Revenue23.86
P/S32.65
P/B1.95
EPS (TTM)-0.96
EPS (Forward)-0.89
52W Range
2.77017% of range7.180
52W High7.180 USD
52W Low2.770 USD
Profitability
Gross Margin4.45%
Oper. Margin-1759.69%
EBITDA Margin0.00%
Profit Margin-868.29%
ROE-57.01%
ROA-43.74%
Growth
Revenue Growth-60.10%
Earnings Growth
Cash Flow & Leverage
Operating CF-371.81M $
CapEx (TTM)8.63M $
FCF Margin-400.13%
FCF Yield-11.69%
Net Debt-479.05M $
Net Debt/EBITDA1.02
Balance Sheet
Debt/Equity0.07
Current Ratio5.03
Quick Ratio4.67
Book Value/Sh1.710 USD
Cash/Share1.019 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.217 USD
Upside (mean)+106.2%
Target Range4.000 USD10.00 USD
$4.000+106.2% to mean$10.00
# Analysts6
Ownership
Shares Out.535.34M
Float518.55M
Insiders2.28%
Institutions70.61%
Short Interest
Short Ratio7.8d
Short % Float35.35%
Short % Out.33.71%
Shares Short180.77M
Short (prev mo.)172.30M
Technical
SMA 503.273 (+6.9%)
SMA 2003.713 (-5.7%)
Beta1.05
S&P 52W Chg18.16%
Avg Vol (30d)17.88M
Avg Vol (10d)14.47M
Technical Indicators
RSI (14)59.7
MACD0.0350
MACD Signal-0.0044
MACD Hist.+0.0393
BB Upper3.511 USD
BB Middle3.180 USD
BB Lower2.850 USD
BB Width20.76%
ATR (14)0.1874 USD
Vol Ratio (20d)1.46x